Mirae Asset Global Etfs Holdings Ltd. Care Dx, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Care Dx, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 68,734 shares of CDNA stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68,734
Previous 108,616
36.72%
Holding current value
$1.04 Million
Previous $1.93 Million
30.31%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CDNA
# of Institutions
210Shares Held
55.8MCall Options Held
85KPut Options Held
33.1K-
Black Rock Inc. New York, NY5.29MShares$80.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$74.6 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.54MShares$38.6 Million0.01% of portfolio
-
Bamco Inc New York, NY2.44MShares$37 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$33.1 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $812M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...